Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death

por Rosso, Melissa, Polotskaia, Alla, Bargonetti, Jill
Publicado 2015

Hot Spot Mutation in TP53 (R248Q) Causes Oncogenic Gain-of-Function Phenotypes in a Breast Cancer Cell Line Derived from an African American patient

por Shtraizent, Nataly, Matsui, Hiroshi, Polotskaia, Alla, Bargonetti, Jill
Publicado 2015

Impedimetric Detection of Mutant p53 Biomarker-Driven Metastatic Breast Cancers under Hyposmotic Pressure

por Shi, Menglu, Shtraizent, Nataly, Polotskaia, Alla, Bargonetti, Jill, Matsui, Hiroshi
Publicado 2014

A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation

por Brekman, Angelika, Singh, Kathryn E, Polotskaia, Alla, Kundu, Nandini, Bargonetti, Jill
Publicado 2011

Correction: A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation

por Brekman, Angelika, Singh, Kathryn E, Polotskaia, Alla, Kundu, Nandini, Bargonetti, Jill
Publicado 2012

Endogenous Human MDM2-C Is Highly Expressed in Human Cancers and Functions as a p53-Independent Growth Activator

por Okoro, Danielle R., Arva, Nicoleta, Gao, Chong, Polotskaia, Alla, Puente, Cindy, Rosso, Melissa, Bargonetti, Jill
Publicado 2013

Identification, validation, and targeting of the mutant p53-PARP-MCM chromatin axis in triple negative breast cancer

por Qiu, Wei-Gang, Polotskaia, Alla, Xiao, Gu, Di, Lia, Zhao, Yuhan, Hu, Wenwei, Philip, John, Hendrickson, Ronald C., Bargonetti, Jill
Publicado 2017